MedTrace Logo

Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer

NCT05150145 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-06-26

No results posted yet for this study

Summary

The aim of this randomized study is to investigate local tumor control,survival outcomes and complications on patients of liver metastasis in small cell lung cancer.

Conditions

  • Radiotherapy; Complications

Interventions

RADIATION

Radiotherpy will be performed to thoracic and liver metastasis after chemotherapy.

Intensity modulated radiotherapy will be performed to liver metastasis and thoracic SCLC patients who achieved CR or PR after chemotherapy .

Sponsors & Collaborators

  • Guizhou Medical University

    lead OTHER

Principal Investigators

  • Shengfa Su, doctor · Affiliated Hospital of Guizhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2026-03-01
Completion
2026-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05150145 on ClinicalTrials.gov